Cargando…
Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature
The identification of the CD20 antigen in 1979 was the first step in what would become a therapeutic milestone opening the use of immunotherapy in hematological diseases. This protein is expressed on the surface of developing B cells, but not the early progenitors or mature plasma cells. In 1997, ri...
Autores principales: | Juárez-Salcedo, Luis Miguel, Conde-Royo, Diego, Quiroz-Cervantes, Keina, Dalia, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216786/ https://www.ncbi.nlm.nih.gov/pubmed/32426017 http://dx.doi.org/10.7573/dic.2019-9-3 |
Ejemplares similares
-
Management of adverse effects of new monoclonal antibody treatments in acute lymphoblastic leukemia
por: Conde-Royo, Diego, et al.
Publicado: (2020) -
Follicular lymphoma and marginal zone lymphoma: how many diseases?
por: Laurent, Camille, et al.
Publicado: (2022) -
Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2021) -
Follicular lymphoma presenting like marginal zone lymphoma: A case report
por: Peng, Hao-Yu, et al.
Publicado: (2022) -
Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada
por: Kuruvilla, John, et al.
Publicado: (2023)